Clinical ethics committee case 9: should we inform our patient about animal products in his medicine?
Dublin Core
Title
Clinical ethics committee case 9: should we inform our patient about animal products in his medicine?
Author
Newson, Ainsley J.
Publisher
2010/03/00
Language
English
Publication Date
20100300
Primary Classification
9.7
Secondary Classification
9.7;1.2;8.3.1;9.5.1;9.6;22.1
Primary keywords
disclosure--[pri];drugs--[pri];hospitals--[pri];informed consent--[pri];institutional ethics--[pri];moral obligations--[pri];Muslims--[pri];patients--[pri];religiously prohibited materials--[pri];values--[pri]
Secondary keywords
alternatives;autonomy;clinical ethics committees;cultural pluralism;ethics consultation;Islamic councils;legal obligations;moral policy;motivation;organizational policies;pharmacists;preventive medicine;religion;resource allocation;selection for treatment
Subject
Clinical Ethics Advisory Group (University Hospitals Bristol NHS Foundation Trust--[pri]
Subject
Great Britain;Muslim Council of Britain;Vegetarian Council (Great Britain)
Subject
heparin--[pri]
Subject
vegetarianism
Journal Article
Clinical Ethics 2010 March; 5(1): 7-12 [Online]. Accessed: http://ce.rsmjournals.com/cgi/reprint/5/1/7 [ 2010 December 15]
Link for Internet access
Primary Document Type
ja
Call Number
citation
Subject Captions
cs
Bibliography
10 fn.
Collection
Citation
“Clinical ethics committee case 9: should we inform our patient about animal products in his medicine?,” Islamic Medical & Scientific Ethics, accessed September 13, 2024, http://imse.ibp.georgetown.domains/items/show/34664.